The Indian Healthcare & Pharma sector has been playing a critical role in driving the growth of the Indian economy and is considered as the key enabler for the vision of India becoming a USD 5 trillion economy in the coming years. The sector plays a crucial role in job creation, investments, innovation, and ESG, among other focus areas.

Dun & Bradstreet India is pleased to launch inaugural edition of “Healthcare & Pharma Summit 2023” on the theme “Prescription for Future Growth”. The summit will be attended by CXOs and other senior management personnel across the healthcare & pharma spectrum, senior officials from government ministries, and policymakers, among others.

The summit will deliberate upon following topics

• ESG in healthcare & pharma
• Affordable healthcare services in India - A distant dream or reality?
• How technology & analytics are re-shaping healthcare & pharma industry?
• The next big growth opportunities for the Indian healthcare industry?
• The path to becoming AtmaNirbhar - Infra, Manpower, Capital, Regulation